As of 2026-09-14, the Fair Value of Vaxcyte Inc (PCVX) is -36.85 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 59.47 USD, the upside of Vaxcyte Inc is -161.97%.
With the market price of 59.47 USD and our fair value calculation, Vaxcyte Inc (PCVX) is not a good investment. Investing in PCVX stocks now will result in a potential loss of 161.97%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -100.08 | -223.49 | -402.27 | -463.93 | -766.63 | -391.28 |
| YoY growth | -12.17% | -123.31% | -79.99% | -15.33% | -65.25% | -59.21% |
| Market Cap (mil) | 8,587.47 |
| P/E | |
| Forward P/E |
| EPS | -7.37 |
| Avg earnings growth rate | -59.21% |
| TTM earnings | -1,064.26 |